Results 151 to 160 of about 3,805,832 (247)

Determinants of Meats Purchase Behavior by Ethnic Groups

Farmers and food companies need to assess their production and marketing strategies for nurturing business opportunities that will arise from the simultaneous increase in population and income of Hispanics in the United States. Previous studies on demand
Garcia-Jimenez, Carlos I., Mishra, Ashok K.   +1 more
core  

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

HLA Alleles and Haplotype Distribution Across Russian Population Groups. [PDF]

Int J Mol Sci
Kucherenko V, Doroschuk N, Sarygina E, Sagaydak O, Bogdanov V, Mityaeva O, Krupinova J, Woroncow M, Albert E, Volchkov P.   +9 more
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Dietary phosphate exposure-strategies to protect vulnerable population groups. [PDF]

Arch Toxicol
Lampen A, Lachenmeier DW, Diel P, Ensenauer R, Frommherz L, Guth S, Humpf HU, Kulling SE, Villar-Fernández MA, Wätjen W, Mally A, Steinberg P.   +11 more
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

Declining use of percutaneous coronary intervention across population groups, 2011-2022. [PDF]

Health Aff Sch
Shteyler VM, Tabas J, Holtzman JN, Shen YC, Hsia RY.   +4 more
europepmc   +1 more source

Dietary Habits and Nutritional Status of Different Population Groups in Relation to Lifestyle Factors and Nutritional Knowledge. [PDF]

Nutrients, 2023
Wawrzyniak A, Pietruszka B.
europepmc   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

PFAS levels and exposure determinants in sensitive population groups. [PDF]

Chemosphere, 2023
Fábelová L, Beneito A, Casas M, Colles A, Dalsager L, Den Hond E, Dereumeaux C, Ferguson K, Gilles L, Govarts E, Irizar A, Lopez Espinosa MJ, Montazeri P, Morrens B, Patayová H, Rausová K, Richterová D, Rodriguez Martin L, Santa-Marina L, Schettgen T, Schoeters G, Haug LS, Uhl M, Villanger GD, Vrijheid M, Zaros C, Palkovičová Murínová Ľ.   +26 more
europepmc   +1 more source